December 10, 2020
from onemarkets blog
| Views: 248
The Scale®30 price index marked a new all-time high today. The main catalyst was the Formycon share, which rose in double digits. The company from Martinsried near Munich announced that a SARS-CoV-2 blocker completely prevents the infection. However, clinical studies are still necessary and approval is not expected until the end of 2022 at the earliest.
In March 2017, Deutsche Börse opened the stock exchange segment for small and medium-sized companies Scale created. Requirements for inclusion in the scale segment include a company history of at least two years and a minimum market capitalization of EUR 30 million. There are currently 46 companies in the scale segment. The Scale® 30 index contains the 30 most liquid stocks that are listed in the Scale stock exchange segment for small and medium-sized enterprises (SMEs). The order book turnover on the Xetra and Börse Frankfurt trading venues is decisive for inclusion in the Scale® 30 index. The weighting in Scale® 30 index is based on market capitalization. The composition is reviewed quarterly and adjusted if necessary. In addition to Formycon, companies such as 2G Energy, Cyan, IBU-tec and Vectron Systems. Participation in the performance of the index via the certificate is one-to-one, which also includes participation in a negative development. Technically, the Scale® 30 index shows an upward trend and today marked a new all-time high. On the bottom, the Scale30 price index finds support in the area of 1,190 points.
Scale 30 index in points; Daily chart
Observation period: March 17th, 2017 (start of index calculation) – December 9th, 2020. Historical considerations are not reliable indicators for future developments. Source: Thomson Reuters
Index certificate on the Scale®30 price index
|HVB Open End Index Certificate|
|Underlying||Scale®30 price index|
|ISIN / WKN||DE000HX5Q1M1“> HX5Q1M / DE000HX5Q1M1|
|running time||Open end *|
|Administration fee p. a.||0.50% p. a.|
|Ask price (selling price)||EUR 138.21|
|* The issuer, UniCredit Bank AG, is entitled to properly terminate the certificate and to repay the respective repayment amount. Status: 09.12.2020, 11:00 a.m.|
NEW: Cashback trading – when the issuer pays my order fees!
Please note the important information and the disclaimer.
This information does not constitute investment advice, but advertising. The public offer is made exclusively on the basis of a securities prospectus approved by the Federal Financial Supervisory Authority (“BaFin”). Approval of the prospectus should not be understood as a recommendation to purchase these UniCredit Bank AG securities. Only the prospectus including any supplements is relevant and the Final Terms. It is recommended that you read these documents carefully before making any investment decision in order to fully understand the potential risks and rewards of investing. You are about to acquire a product that is not easy and can be difficult to understand.
How the HVB products work
The article Scale 30: Formycon with Covid-19 blocker first appeared on onemarkets blog (HypoVereinsbank – UniCredit Bank AG).
Author: Richard Pfadenhauer
PERSONAL-FINANCIAL.COM publishes analyzes, columns and news from various sources in this section.
PERSONAL-FINANCIAL.COM AG is not responsible for content that is recognizable by third parties in the “News” area
This website has been discontinued and does not adopt it as its own. These contents are in particular through
a corresponding “from” mark below the article heading and / or through the link
“To read the full article, please click here.” responsible for
this content is solely the named third party.
Other users were also interested in this article: